Skip to main content
logo
GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,530.00
-50.00 (-0.90%)
At close: Aug 24, 2026

GFC Life Science Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '21 Dec '20 Dec '19
Net Income
1,076555.43-5,9471,617-2,863448.7
Depreciation & Amortization
1,8561,7161,583903.41762.56794.15
Loss (Gain) From Sale of Assets
-179.49-5.3144.53-172.58--835.46
Asset Writedown & Restructuring Costs
---42.7296.86-
Loss (Gain) From Sale of Investments
233.9499.226,055-54.29-43.9-69.65
Loss (Gain) on Equity Investments
----323.54-217.23
Stock-Based Compensation
61.84106.39671.1968.22-
Provision & Write-off of Bad Debts
-6.97-4.57-40.0333.95-17.430.25
Other Operating Activities
-167.14-338.491,327-118.282,68925.34
Change in Accounts Receivable
-446.8-819.99-277.5483.48-31.51-53.89
Change in Inventory
-645.5-31.23-24.4529.81-251.58409.69
Change in Accounts Payable
84.761.43-139.06-127.5-9.87125.81
Change in Unearned Revenue
-----7.410.38
Change in Income Taxes
-----15.94-99.12
Change in Other Net Operating Assets
312.1788.4289.21-1,368-40.91-939.38
Operating Cash Flow
2,1781,3672,967941.21659.42-410.42
Operating Cash Flow Growth
15.20%-53.93%215.23%42.73%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '21 Dec '20 Dec '19
Capital Expenditures
-9,092-7,712-3,003-584.07-2,593-3,597
Sale of Property, Plant & Equipment
201510.913,184-1,199
Cash Acquisitions
---31.1-1,954
Sale (Purchase) of Intangibles
-430.58-310.24-67.17-13.73-15.85
Investment in Securities
-905.17101.46-89.14627.17-648.42-247.34
Other Investing Activities
-10.99-35.49108.32-214.0150.68-0
Investing Cash Flow
-10,409-7,621-2,6642,977-3,139-1,157

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '21 Dec '20 Dec '19
Short-Term Debt Issued
--5001,5162,166500
Long-Term Debt Issued
-3,6006507701,1002,200
Total Debt Issued
4,9003,6001,1502,2863,2662,700
Short-Term Debt Repaid
--1,000-950-2,012-1,086-
Long-Term Debt Repaid
--2,421-623.94-3,148-336.12-1,396
Total Debt Repaid
-3,428-3,421-1,574-5,160-1,422-1,396
Net Debt Issued (Repaid)
1,472178.98-423.94-2,8741,8441,304
Issuance of Common Stock
597.7711,995139.51---
Repurchase of Common Stock
-----200-
Other Financing Activities
010----
Financing Cash Flow
2,07012,183-284.43-2,8741,6441,304

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '21 Dec '20 Dec '19
Foreign Exchange Rate Adjustments
58.762.3835.95---
Miscellaneous Cash Flow Adjustments
-----0
Net Cash Flow
-6,1025,93254.721,044-835.31-263.64

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '21 Dec '20 Dec '19
Free Cash Flow
-6,914-6,345-35.83357.14-1,934-4,007
Free Cash Flow Growth
------
Free Cash Flow Margin
-35.94%-35.82%-0.21%2.60%-14.51%-33.65%
Free Cash Flow Per Share
-1314.06-1317.13-11.28344.54-1865.79-3867.17
Levered Free Cash Flow
-7,509-6,657--236.89-464.03-3,086
Unlevered Free Cash Flow
-7,306-6,470--100.59-335.61-2,949

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2021FY 2020FY 2019
Period Ending
Jun '26 Dec '25 Dec '24 Dec '21 Dec '20 Dec '19
Cash Interest Paid
252.41214.44242.67---
Cash Income Tax Paid
12.8410.852.23---
Change in Working Capital
-695.38-761.4-151.83-1,382-357.22-556.51